Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21+
SponsorM.D. Anderson Cancer Center
About this trial
This study formulates consensus agreement on clinical key elements related to prostate cancer care that are critical for standardization and global reported using a robust Delphi technique, completely remote and electronic. The goal of this survey study is to have a panel of specialty-specific experts create a consensus agreement on a minimum set of key data elements for use in standardized reports. These recommendations would be used to develop standardized methods to report key data in electronic health records to better manage cancer patients at time of diagnosis, treatment, follow up, and into survivorship.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age 21 and above
Board certification in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology
Maintenance of an active practice that includes prostate cancer patients
English speaking
Disqualifiers
Medical providers that are not board certified in the professions and/or those who do not treat prostate cancer
Prisoners, children, and adults unable to consent to participation will also be excluded
No exclusions were made based on sex, age, racial/ethnic background, or pregnancy status
Trial population
Participants with board certification in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Questionnaire Administration
Other interventionComplete questionnaires
Treatment groups
10 Participants
are divided into 1 treatment groupGroup A: Observational (questionnaire)1 intervention
Trial outcomes
Primary outcomes
1
To establish a standardized methods to report key data in electronic health records to better manage cancer patients at time of diagnosis, treatment, follow up, and into survivor-ship.
Time frame
through study completion, an average of a year.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov